论文部分内容阅读
目的对双歧三联活菌片联合蒙脱石散在小儿腹泻疾病治疗中的疗效进行观察。方法将94例小儿腹泻患者按就诊的前后顺序分为两组,即甲组与乙组,其中,对甲组患者予以双歧三联活菌片(金双歧)联合蒙脱石散(思密达)予以治疗,对乙组患者予以常规治疗法进行治疗,然后对2组患者的疗效加以观察与比较。结果甲组中患者的有效率(95.24%)与乙组中患者的有效率(78.57%)相比,明显较高,差异有统计学意义(P<0.05);甲组患者大便次数恢复正常、体温恢复正常以及大便性状恢复正常等的时间均乙组相比,差异有统计学意义(P<0.05)。结论对小儿腹泻患者采取双歧三联活菌片联合蒙脱石散进行治疗,可获得较为满意的效果,值得大力推广与使用。
Objective To observe the efficacy of Bifidobacterium triptychia combined with montmorillonite powder in the treatment of children with diarrhea. Methods Ninety-four pediatric patients with diarrhea were divided into two groups according to the order of treatment: Group A and Group B. Patients in Group A were treated with bifidobacterium triple viable tablets (Jinshuangqi) combined with montmorillonite powder (Smectite) To be treated, the patients in Group B to be treated by conventional therapy, and then the efficacy of the two groups were observed and compared. Results The effective rate of patients in group A (95.24%) was significantly higher than that of patients in group B (78.57%) (P <0.05). The number of stool in group A returned to normal, Body temperature returned to normal and the stool trait returned to normal in the time of B group, the difference was statistically significant (P <0.05). Conclusion The treatment of children with diarrhea with bifid triple viable tablets combined with montmorillonite powder can obtain more satisfactory results and is worthy of promotion and use.